Next Article in Journal
Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure
Next Article in Special Issue
Looking for Novel Capsid Protein Multimerization Inhibitors of Feline Immunodeficiency Virus
Previous Article in Journal
The Role of TRP Channels in the Metastatic Cascade
Previous Article in Special Issue
NUC041, a Prodrug of the DNA Methytransferase Inhibitor 5-aza-2′,2′-Difluorodeoxycytidine (NUC013), Leads to Tumor Regression in a Model of Non-Small Cell Lung Cancer
Article Menu
Issue 2 (June) cover image

Export Article

Open AccessArticle
Pharmaceuticals 2018, 11(2), 49;

A Short Peptide Inhibitor as an Activity-Based Probe for Matriptase-2

Pharmaceutical Chemistry I, Pharmaceutical Institute, University of Bonn, Bonn 53113, Germany
Author to whom correspondence should be addressed.
Received: 30 April 2018 / Revised: 15 May 2018 / Accepted: 17 May 2018 / Published: 21 May 2018
Full-Text   |   PDF [7069 KB, uploaded 21 May 2018]   |  


Matriptase-2 is a type II transmembrane serine protease and a key regulator of systemic iron homeostasis. Since the activation mechanism and several features of the physiological role of matriptase-2 are not fully understood, there is strong need for analytical tools to perform tasks such as distinguishing active and inactive matriptase-2. For this purpose we present a short biotinylated peptide derivative with a chloromethyl ketone group, biotin-RQRR-CMK, as an activity-based probe for matriptase-2. Biotin-RQRR-CMK was kinetically characterized and exhibited a second-order rate constant of inactivation (kinac/Ki) of 10,800 M−1 s−1 towards the matriptase-2 activity in the supernatant of transfected human embryonic kidney (HEK) cells. Biotin-RQRR-CMK was able to label active matriptase-2, as visualized in western blot experiments. Pretreatment with aprotinin, an active-site directed inhibitor of serine proteases, protected matriptase-2 from the reaction with biotin-RQRR-CMK. View Full-Text
Keywords: matriptase-2; Activity-based probe; peptide inhibitor matriptase-2; Activity-based probe; peptide inhibitor

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Mangold, M.; Gütschow, M.; Stirnberg, M. A Short Peptide Inhibitor as an Activity-Based Probe for Matriptase-2. Pharmaceuticals 2018, 11, 49.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top